{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T18:28:45Z","timestamp":1759602525036},"publisher-location":"Singapore","reference-count":45,"publisher":"Springer Singapore","isbn-type":[{"type":"print","value":"9789813296350"},{"type":"electronic","value":"9789813296367"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-32-9636-7_20","type":"book-chapter","created":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T18:02:52Z","timestamp":1574532172000},"page":"323-331","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Guillain\u2013Barr\u00e9 Syndrome"],"prefix":"10.1007","author":[{"given":"Kenichi","family":"Kaida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,24]]},"reference":[{"key":"20_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0165-5728(90)90082-X","volume":"26","author":"DR Cornblath","year":"1990","unstructured":"Cornblath DR, Griffin DE, Welch D et al (1990) Quantitative analysis of endoneurial T-cells in human sural nerve biopsies. J Neuroimmunol 26:113\u2013118","journal-title":"J Neuroimmunol"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1093\/brain\/aww189","volume":"139","author":"K Doppler","year":"2016","unstructured":"Doppler K, Appeltshauser L, Villmann C et al (2016) Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy. Brain 139:2617\u20132630","journal-title":"Brain"},{"key":"20_CR3","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/brain\/109.6.1115","volume":"109","author":"TE Feasby","year":"1986","unstructured":"Feasby TE, Gilbert JJ, Brown WF et al (1986) An acute axonal form of Guillain-Barr\u00e9 polyneuropathy. Brain 109:1115\u20131126","journal-title":"Brain"},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0022-510X(93)90324-R","volume":"116","author":"TE Feasby","year":"1993","unstructured":"Feasby TE, Hahn AF, Brown WF et al (1993) Severe axonal degeneration in acute Guillain-Barr\u00e9 syndrome: evidence of two different mechanisms? J Neurol Sci 116:185\u2013192","journal-title":"J Neurol Sci"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/jnnp-2016-315480","volume":"89","author":"J Fehmi","year":"2018","unstructured":"Fehmi J, Scherer SS, Willison HJ et al (2018) Nodes, paranodes and neuropathies. J Neurol Neurosurg Psychiatry 89:61\u201371. \nhttps:\/\/doi.org\/10.1136\/jnnp-2016-315480","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/cen3.12461","volume":"9","author":"T Fujioka","year":"2018","unstructured":"Fujioka T (2018) Experimental autoimmune neuritis. Clin Exp Neuroimmunol 9:84\u201392. \nhttps:\/\/doi.org\/10.1111\/cen3.12461","journal-title":"Clin Exp Neuroimmunol"},{"key":"20_CR7","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/B978-0-7216-9491-7.50101-0","volume-title":"Peripheral neuropathy","author":"JW Griffin","year":"2005","unstructured":"Griffin JW, Sheikh K (2005) The Guillain-Barr\u00e9 syndromes. In: Thomas PK, Dyck PJ (eds) Peripheral neuropathy, 4th edn. Elsevier Saunders, Philadelphia, PA, pp 2197\u20132219","edition":"4"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/brain\/118.3.577","volume":"118","author":"JW Griffin","year":"1995","unstructured":"Griffin JW, Li CY, Ho TW et al (1995) Guillain-Barr\u00e9 syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 118:577\u2013595","journal-title":"Brain"},{"key":"20_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ana.410390105","volume":"39","author":"JW Griffin","year":"1996","unstructured":"Griffin JW, Li CY, Ho TW et al (1996a) Pathology of the motor sensory axonal Guillain-Barr\u00e9 syndrome. Ann Neurol 39:17\u201328. \nhttps:\/\/doi.org\/10.1002\/ana.410390105","journal-title":"Ann Neurol"},{"key":"20_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF02284784","volume":"25","author":"JW Griffin","year":"1996","unstructured":"Griffin JW, Li CY, Macko C et al (1996b) Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barr\u00e9 syndrome. J Neurocytol 25:33\u201351","journal-title":"J Neurocytol"},{"key":"20_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/ana.410390512","volume":"39","author":"CE Hafer-Macko","year":"1996","unstructured":"Hafer-Macko CE, Sheikh KA, Li CY et al (1996a) Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 39:625\u2013635. \nhttps:\/\/doi.org\/10.1002\/ana.410390512","journal-title":"Ann Neurol"},{"key":"20_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.410400414","volume":"40","author":"C Hafer-Macko","year":"1996","unstructured":"Hafer-Macko C, Hsieh ST, Li CY et al (1996b) Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 40:635\u2013644. \nhttps:\/\/doi.org\/10.1002\/ana.410400414","journal-title":"Ann Neurol"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/brain\/awm316","volume":"131","author":"SK Halstead","year":"2008","unstructured":"Halstead SK, Zitman FM, Humphreys PD et al (2008) Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain 131:1197\u20131208. \nhttps:\/\/doi.org\/10.1093\/brain\/awm316","journal-title":"Brain"},{"key":"20_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00005792-194902010-00003","volume":"28","author":"WE Haymaker","year":"1949","unstructured":"Haymaker WE, Kernohan JW (1949) The Landry-Guillain-Barr\u00e9 syndrome; a clinicopathologic report of 50 fatal cases and a critique of the literature. Medicine 28:59\u2013141","journal-title":"Medicine"},{"key":"20_CR15","doi-asserted-by":"publisher","first-page":"6770","DOI":"10.1523\/JNEUROSCI.4926-14.2015","volume":"35","author":"L He","year":"2015","unstructured":"He L, Zhang G, Liu W et al (2015) Anti-ganglioside antibodies induce nodal and axonal injury via Fcc receptor-mediated inflammation. J Neurosci 35:6770\u20136785. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.4926-14.2015","journal-title":"J Neurosci"},{"key":"20_CR16","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1212\/WNL.48.3.717","volume":"48","author":"TW Ho","year":"1997","unstructured":"Ho TW, Hsieh ST, Nachamkin I et al (1997) Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology 48:717\u2013724","journal-title":"Neurology"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0165-5728(82)90071-6","volume":"2","author":"H Kalimo","year":"1982","unstructured":"Kalimo H, Moln\u00e1r GK, Saksa M et al (1982) Involvement of autonomic nervous system in experimental allergic neuritis. A light- and electron-microscopic study. J Neuroimmunol 2:9\u201319","journal-title":"J Neuroimmunol"},{"key":"20_CR18","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1136\/jnnp.52.7.857","volume":"52","author":"T Kanda","year":"1989","unstructured":"Kanda T, Hayashi H, Tanabe H et al (1989) A fulminant case of Guillain-Barr\u00e9 syndrome: topographic and fibre size related analysis of demyelinating changes. J Neurol Neurosurg Psychiatry 52:857\u2013864","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"20_CR19","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1212\/WNL.51.6.1656","volume":"51","author":"S Kuwabara","year":"1998","unstructured":"Kuwabara S, Asahina M, Koga M et al (1998a) Two patterns of clinical recovery in Guillain-Barr\u00e9 syndrome with IgG anti-GM1 antibody. Neurology 51:1656\u20131660","journal-title":"Neurology"},{"key":"20_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/ana.410440210","volume":"44","author":"S Kuwabara","year":"1998","unstructured":"Kuwabara S, Yuki N, Koga M et al (1998b) IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barr\u00e9 syndrome. Ann Neurol 44:202\u2013208. \nhttps:\/\/doi.org\/10.1002\/ana.410440210","journal-title":"Ann Neurol"},{"key":"20_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2011.08.016","volume":"239","author":"M Kuwahara","year":"2011","unstructured":"Kuwahara M, Suzuki S, Takada K et al (2011) Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 239:87\u201390. \nhttps:\/\/doi.org\/10.1016\/j.jneuroim.2011.08.016","journal-title":"J Neuroimmunol"},{"key":"20_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/BF00688825","volume":"8","author":"H Matsuyama","year":"1967","unstructured":"Matsuyama H, Haymaker W (1967) Distribution of lesions in the Landry-Guillain-Barr\u00e9 syndrome, with emphasis on involvement of the sympathetic system. Acta Neuropathol 8:230\u2013241","journal-title":"Acta Neuropathol"},{"key":"20_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/ana.410330402","volume":"33","author":"GM McKhann","year":"1993","unstructured":"McKhann GM, Cornblath DR, Griffin JW et al (1993) Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 33:333\u2013342. \nhttps:\/\/doi.org\/10.1002\/ana.410330402","journal-title":"Ann Neurol"},{"key":"20_CR24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1474-4422(18)30114-5","volume":"17","author":"S Misawa","year":"2018","unstructured":"Misawa S, Kuwabara S, Sato Y et al (2018) Safety and efficacy of eculizumab in Guillain-Barr\u00e9 syndrome: a multicentre, double-blind, randomised phase 2 trial. Lancet Neurol 17:519\u2013529. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(18)30114-5","journal-title":"Lancet Neurol"},{"key":"20_CR25","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/0002-9343(67)90079-4","volume":"42","author":"PL Mitchell","year":"1967","unstructured":"Mitchell PL, Meilman E (1967) The mechanism of hypertension in the Guillain-Barr\u00e9 syndrome. Am J Med 42:986\u2013995","journal-title":"Am J Med"},{"key":"20_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF00688126","volume":"67","author":"MK Morey","year":"1985","unstructured":"Morey MK, Wiley CA, Hughes RA et al (1985) Autonomic nerves in experimental allergic neuritis in the rat. Acta Neuropathol 67:75\u201380","journal-title":"Acta Neuropathol"},{"key":"20_CR27","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","volume":"79","author":"JK Ng","year":"2012","unstructured":"Ng JK, Malotka J, Kawakami N et al (2012) Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology 79:2241\u20132248","journal-title":"Neurology"},{"key":"20_CR28","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1126\/science.451555","volume":"204","author":"T Saida","year":"1979","unstructured":"Saida T, Saida K, Dorfman SH et al (1979) Experimental allergic neuritis induced by sensitization with galactocerebroside. Science 204:1103\u20131106","journal-title":"Science"},{"key":"20_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jns.2013.11.016","volume":"337","author":"M Samukawa","year":"2014","unstructured":"Samukawa M, Hamada Y, Kuwahara M et al (2014) Clinical features in Guillain-Barr\u00e9 syndrome with anti-Gal-C antibody. J Neurol Sci 337:55\u201360. \nhttps:\/\/doi.org\/10.1016\/j.jns.2013.11.016","journal-title":"J Neurol Sci"},{"key":"20_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jneuroim.2016.10.006","volume":"301","author":"M Samukawa","year":"2016","unstructured":"Samukawa M, Kuwahara M, Morikawa M et al (2016) Electrophysiological assessment of Guillain-Barr\u00e9 syndrome with both Gal-C and ganglioside antibodies; tendency for demyelinating type. J Neuroimmunol 301:61\u201364. \nhttps:\/\/doi.org\/10.1016\/j.jneuroim.2016.10.006","journal-title":"J Neuroimmunol"},{"key":"20_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1212\/WNL.0000000000000566","volume":"83","author":"S Sawai","year":"2014","unstructured":"Sawai S, Satoh M, Mori M et al (2014) Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barr\u00e9 syndrome. Neurology 83:113\u2013117. \nhttps:\/\/doi.org\/10.1212\/WNL.0000000000000566","journal-title":"Neurology"},{"key":"20_CR32","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1212\/WNL.48.6.1694","volume":"48","author":"G Sobue","year":"1997","unstructured":"Sobue G, Li M, Terao S et al (1997) Axonal pathology in Japanese Guillain-Barr\u00e9 syndrome: a study of 15 autopsied cases. Neurology 48:1694\u20131700","journal-title":"Neurology"},{"key":"20_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1600-0404.1985.tb01542.x","volume":"72","author":"G Solders","year":"1985","unstructured":"Solders G, Persson A, Kristensson K et al (1985) Autonomic dysfunction in experimental allergic neuritis. Acta Neurol Scand 72:18\u201325","journal-title":"Acta Neurol Scand"},{"key":"20_CR34","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/cen3.12338","volume":"7","author":"K Susuki","year":"2016","unstructured":"Susuki K (2016) Node of Ranvier disruption in Guillain\u2013Barr\u00e9 syndrome. Clin Exp Neuroimmunol 7:324\u2013329. \nhttps:\/\/doi.org\/10.1111\/cen3.12338","journal-title":"Clin Exp Neuroimmunol"},{"key":"20_CR35","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1523\/JNEUROSCI.4401-06.2007","volume":"27","author":"K Susuki","year":"2007","unstructured":"Susuki K, Rasband MN, Tohyama K et al (2007) Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 27:3956\u20133967. \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.4401-06.2007","journal-title":"J Neurosci"},{"key":"20_CR36","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.expneurol.2011.11.039","volume":"233","author":"K Susuki","year":"2012","unstructured":"Susuki K, Yuki N, Schafer DP et al (2012) Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies. Exp Neurol 233:534\u2013542. \nhttps:\/\/doi.org\/10.1016\/j.expneurol.2011.11.039","journal-title":"Exp Neurol"},{"key":"20_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.expneurol.2007.09.010","volume":"209","author":"K Takada","year":"2008","unstructured":"Takada K, Shimizu J, Kusunoki S (2008) Apoptosis of primary sensory neurons in GD1b-induced sensory ataxic neuropathy. Exp Neurol 209:279\u2013283. \nhttps:\/\/doi.org\/10.1016\/j.expneurol.2007.09.010","journal-title":"Exp Neurol"},{"key":"20_CR38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.mcn.2010.07.008","volume":"45","author":"A Ueda","year":"2010","unstructured":"Ueda A, Shima S, Miyashita T et al (2010) Anti-GM1 antibodies affect the integrity of lipid rafts. Mol Cell Neurosci 45:355\u2013362. \nhttps:\/\/doi.org\/10.1016\/j.mcn.2010.07.008","journal-title":"Mol Cell Neurosci"},{"key":"20_CR39","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jnnp-2014-310097","volume":"86","author":"A Uncini","year":"2015","unstructured":"Uncini A, Kuwabara S (2015) Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatry 86:1186\u20131195. \nhttps:\/\/doi.org\/10.1136\/jnnp-2014-310097","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"20_CR40","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1136\/jnnp-2017-317192","volume":"89","author":"A Uncini","year":"2018","unstructured":"Uncini A, Vallat JM (2018) Autoimmune nodo-paranodopathies of peripheral nerve: the concept is gaining ground. J Neurol Neurosurg Psychiatry 89:627\u2013635. \nhttps:\/\/doi.org\/10.1136\/jnnp-2017-317192","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"20_CR41","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/brain\/awg207","volume":"126","author":"J Wanschitz","year":"2003","unstructured":"Wanschitz J, Maier H, Lassmann H et al (2003) Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barr\u00e9 syndrome. Brain 126:2034\u20132042. \nhttps:\/\/doi.org\/10.1093\/brain\/awg207","journal-title":"Brain"},{"key":"20_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0022-510X(99)00174-4","volume":"168","author":"K Yako","year":"1999","unstructured":"Yako K, Kusunoki S, Kanazawa I (1999) Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barr\u00e9 syndrome. J Neurol Sci 168:85\u201389","journal-title":"J Neurol Sci"},{"key":"20_CR43","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung HP (2012) Guillain-Barr\u00e9 Syndrome. N Engl J Med 366:2294\u20132304. \nhttps:\/\/doi.org\/10.1056\/NEJMra1114525","journal-title":"N Engl J Med"},{"key":"20_CR44","doi-asserted-by":"publisher","first-page":"11404","DOI":"10.1073\/pnas.0402391101","volume":"101","author":"N Yuki","year":"2004","unstructured":"Yuki N, Susuki K, Koga M et al (2004) Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A 101:11404\u201311409. \nhttps:\/\/doi.org\/10.1073\/pnas.0402391101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20_CR45","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/mus.880171004","volume":"17","author":"DW Zochodne","year":"1994","unstructured":"Zochodne DW (1994) Autonomic involvement in Guillain-Barr\u00e9 syndrome: a review. Muscle Nerve 17:1145\u20131155. \nhttps:\/\/doi.org\/10.1002\/mus.880171004","journal-title":"Muscle Nerve"}],"container-title":["Advances in Experimental Medicine and Biology","Myelin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-32-9636-7_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T18:03:47Z","timestamp":1574532227000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-32-9636-7_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789813296350","9789813296367"],"references-count":45,"URL":"https:\/\/doi.org\/10.1007\/978-981-32-9636-7_20","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"24 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}